Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
急性至持续性风疹病毒感染期间获得的补体耐药性
基本信息
- 批准号:10645486
- 负责人:
- 金额:$ 24.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-23 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAirBindingBiochemicalBiological AssayCell Culture TechniquesCell LineCell SurvivalCellsClinicalClinical TrialsComplementComplement Factor HComplement InactivatorsCytolysisDataDrug ModulationEngineeringEnvironmentEpithelial CellsFibrinogenFutureGenetic PolymorphismGenomeGoalsHumanIn VitroInfectionInflammationInnate Immune SystemLiquid substanceLungLung infectionsMediatingMumps virusParamyxovirusPathway interactionsPopulationProductionProteomicsRNA Virus InfectionsResistanceRespiratory SystemRespiratory Tract InfectionsRoleRubulavirusRubulavirus InfectionsSeveritiesSurfaceTestingTherapeuticTimeTracheaVariantViralViral Respiratory Tract InfectionVirionVirusVirus DiseasesVirus ReplicationVitronectinWorkacute infectionchronic infectionconditioninggene complementationinhibitorinnate immune mechanismsinnate immune pathwaysinterestparainfluenza viruspathogenprototyperecruitrespiratoryrespiratory infection virusresponsesulfated glycoprotein 2transcriptomics
项目摘要
For many RNA virus infections, an initial acute infection can transition to a prolonged or persistent
infection, in which infected cells survive and continue to produce progeny virus. Complement (C’) is a
powerful innate immune system which can directly lyse virus-infected cells or neutralize virus (1-4), but
the role of C’ in controlling persistent respiratory RNA virus infections is not well understood. Given that
viruses have mechanisms to block C’-mediated cell lysis, persistent infections can set up a prolonged
inflammation cycle – where activated C’ continues to provide damaging inflammation, but viral inhibitory
mechanisms block elimination of pathogen and infected cells.
This project emerged from our striking findings that during an initial acute infection of human lung
cells with the Rubulavirus Parainfluenza virus 5 (PIV5), infected cells are very sensitive to C’-mediated
lysis. Importantly however, after transitioning to a persistent infection, PIV5-infected cells are nearly
completely resistant to C’ lysis. Our transcriptomics data show that PIV5 acutely infected cells have low
level expression of C’ inhibitors, but this shifts to high level expression of cellular C’ inhibitors Factor H,
Factor I, Vitronectin and Clusterin in persistently infected cells.
Our central hypothesis is that PIV5 persistently infected cells acquire resistance to C’-mediated
lysis due to their acquired ability to express high levels of C’ inhibitors Factor H and Vitronectin. Our
goals are to identify: 1) the mechanisms for acquiring C’ resistance during the PIV5 acute-to-persistent
transition (Aim 1), and 2) consequences of this shift for production of C’-resistant virus (Aim 2).
Aim 1 will define the mechanism for differential sensitivity of airway cells to C’-mediated lysis
during transition from acute to persistent infection. Engineered respiratory tract cell lines and primary
tracheal or bronchial air-liquid interface (ALI) cell cultures will be used to test the hypothesis that
synthesis of C’ inhibitors Factor H and Vitronectin by persistently infected cells results in conditioning of
the cells to be resistant to C’-mediated lysis. Aim 2 will identify C’ factors associated with virus particles
derived from acute versus persistently infected cells and define the sensitivity of persistent virus to C’-
mediated neutralization. Proteomics and biochemical assays will test the hypothesis that virus derived
from persistently infected cells will be C’-resistant due to recruitment of Factor H or Vitronectin.
Results from our work on C’ interactions with persistent RNA virus infections will have strong
potential to inform therapeutics, given: 1) the clinical impact of prolonged viral respiratory infections, 2)
polymorphisms in C’ genes can correlate with severity of viral infections, and 3) clinical trials for
respiratory tract infections are underway with drugs that modulate C’ responses.
对于许多rna病毒感染来说,最初的急性感染可以转变为长期或持久的
感染,受感染的细胞存活并继续产生后代病毒。补语(C‘)是一个
强大的天然免疫系统,可直接溶解受病毒感染的细胞或中和病毒(1-4),但
C‘在控制持续呼吸道RNA病毒感染中的作用尚不清楚。考虑到
病毒有阻止C‘介导的细胞裂解的机制,持续感染可以建立长期的
炎症循环-激活的C‘继续提供破坏性炎症,但对病毒有抑制作用
机制阻止了病原体和受感染细胞的清除。
这个项目是从我们惊人的发现中产生的,在人类肺部最初的急性感染期间
与风疹病毒副流感病毒5(PIV5)感染的细胞对C‘介导的反应非常敏感
解体。然而,重要的是,在过渡到持续感染后,感染PIV5的细胞几乎
完全抵抗C‘lysis。我们的转录学数据显示,PIV5急性感染的细胞具有低水平的
C‘抑制因子的水平表达,但这转移到细胞C’抑制因子H的高水平表达,
持续感染细胞中的凝集素、凝集素和凝集素。
我们的中心假设是PIV5持续感染的细胞对C‘介导的
裂解是由于它们获得了表达高水平的C‘抑制因子H和玻璃连蛋白的能力。我们的
目标是确定:1)在PIV5从急性到持续性期间获得C‘抵抗的机制
转变(目标1),以及2)这种转变对C‘耐药病毒生产的后果(目标2)。
目标1将确定呼吸道细胞对C‘介导的裂解的差异敏感性的机制
在从急性感染向持续性感染过渡期间。工程化呼吸道细胞系及原代培养
气管或支气管气液界面(ALI)细胞培养将被用来检验这一假设
持续感染细胞合成C‘抑制因子H和Vitronectin导致条件化
这些细胞对C‘介导的裂解具有抵抗力。目标2将确定与病毒颗粒相关的C‘因子
来自急性感染细胞和持续感染细胞,并确定了持续病毒对C‘-
中介中和。蛋白质组学和生化分析将检验病毒起源于
持续感染的细胞由于凝血因子H或玻璃凝集素的募集而具有C‘抗性。
我们在C‘与持续RNA病毒感染相互作用方面的工作结果将会有很强的
给治疗提供信息的可能性:1)长期病毒呼吸道感染的临床影响,2)
C‘基因的多态可以与病毒感染的严重程度相关,以及3)临床试验
呼吸道感染正在通过调节C‘反应的药物进行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Griffith D. Parks其他文献
Complement evasion by vesicular stomatitis virus involves recruitment of host complement regulatory proteins
- DOI:
10.1016/j.molimm.2010.05.129 - 发表时间:
2010-08-01 - 期刊:
- 影响因子:
- 作者:
John B. Johnson;Douglas S. Lyles;Griffith D. Parks - 通讯作者:
Griffith D. Parks
Griffith D. Parks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Griffith D. Parks', 18)}}的其他基金
Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
- 批准号:
8470128 - 财政年份:2012
- 资助金额:
$ 24.12万 - 项目类别:
Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
- 批准号:
8896985 - 财政年份:2012
- 资助金额:
$ 24.12万 - 项目类别:
Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
- 批准号:
8358727 - 财政年份:2012
- 资助金额:
$ 24.12万 - 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
- 批准号:
8286153 - 财政年份:2011
- 资助金额:
$ 24.12万 - 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
- 批准号:
8897063 - 财政年份:2011
- 资助金额:
$ 24.12万 - 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
- 批准号:
8469683 - 财政年份:2011
- 资助金额:
$ 24.12万 - 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
- 批准号:
8848749 - 财政年份:2011
- 资助金额:
$ 24.12万 - 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
- 批准号:
8660023 - 财政年份:2011
- 资助金额:
$ 24.12万 - 项目类别:
Paramyxovirus Activation and Inhibition of Complement Pathways
副粘病毒激活和补体途径的抑制
- 批准号:
8039506 - 财政年份:2011
- 资助金额:
$ 24.12万 - 项目类别:
Complement-mediated Neutralization of Mumps Virus and SV5
补体介导的腮腺炎病毒和 SV5 的中和
- 批准号:
8069009 - 财政年份:2010
- 资助金额:
$ 24.12万 - 项目类别:
相似国自然基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
- 批准号:51976048
- 批准年份:2019
- 资助金额:61.0 万元
- 项目类别:面上项目
相似海外基金
COMPAS: co integration of microelectronics and photonics for air and water sensors
COMPAS:微电子学和光子学的共同集成,用于空气和水传感器
- 批准号:
10108154 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
EU-Funded
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Standard Grant
SBIR Phase I: High-Efficiency Liquid Desiccant Regenerator for Desiccant Enhanced Evaporative Air Conditioning
SBIR 第一阶段:用于干燥剂增强蒸发空调的高效液体干燥剂再生器
- 批准号:
2335500 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Standard Grant
Catalyzing Sustainable Air Travel: Unveiling Consumer Willingness to Pay for Sustainable Aviation Fuel through Information Treatment in Choice Experiment and Cross-Country Analysis
促进可持续航空旅行:通过选择实验和跨国分析中的信息处理揭示消费者支付可持续航空燃油的意愿
- 批准号:
24K16365 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Phenotypic and lineage diversification after key innovation(s): multiple evolutionary pathways to air-breathing in labyrinth fishes and their allies
合作研究:关键创新后的表型和谱系多样化:迷宫鱼及其盟友呼吸空气的多种进化途径
- 批准号:
2333683 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Continuing Grant
Collaborative Research: Phenotypic and lineage diversification after key innovation(s): multiple evolutionary pathways to air-breathing in labyrinth fishes and their allies
合作研究:关键创新后的表型和谱系多样化:迷宫鱼及其盟友呼吸空气的多种进化途径
- 批准号:
2333684 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Continuing Grant
CRII: CSR: Towards an Edge-enabled Software-Defined Vehicle Framework for Dynamic Over-the-Air Updates
CRII:CSR:迈向支持边缘的软件定义车辆框架,用于动态无线更新
- 批准号:
2348151 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Standard Grant
Smoldering coarse woody debris and air quality
阴燃粗木质碎片和空气质量
- 批准号:
IM240100016 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Mid-Career Industry Fellowships
Simulating Urban Air Pollution In The Lab
在实验室模拟城市空气污染
- 批准号:
MR/Y020014/1 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Fellowship
Development of a low-pressure loss air purification device using rotating porous media and a proposal for its use in ventilation systems
使用旋转多孔介质的低压损失空气净化装置的开发及其在通风系统中的使用建议
- 批准号:
24K17404 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists